Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia

European Journal of Pharmacology

Volumn 327, Issue 1, 1997, Pages 11-16

  Ren, Jingmei ^a   Finklestein, Seth P ^a  

^a CNS Growth Factor Res Laboratory   (United States)

Author keywords

BFGF (basic nbroblast growth factor); Cerebral isthemia; Focal

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030915451     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)89672-0     Document Type: Article

References (25)

1. Baird A. Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors. Curr. Opin. Neurobiol. 4:1994;78-86.
2. Bethel, A., Kirsch, J.R., Koehler, R.C., Finklestein, S.P., Traystman, R.J., Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke (in press).
3. Chen, K., Finklestein, S.P., Neurotrophic factors. In: Hsu, C.Y. (Ed.), Ischemic Stroke. From Basic Mechanisms to New Drug Development. Karger, Basel (in press).
4. Finklestein S.P., Kemmou A., Caday C.G., Berlove D.J. Basic fibroblast growth factor protects cerebrocortical neurons against excitatory amino acid toxicity in vitro. Stroke. 24(Suppl. 1):1993;I141-I143.
5. Fisher M., Takano K. The penumbra, therapeutic time window and acute ischemic stroke. Bailliere's Clin. Neurol. 4:1995;279-295.
6. Fisher M., Meadows M.-E., Do T., Weise J., Trubetskoy V., Charette M., Finklestein S.P. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;953-959.
7. Hatfield R.H., Gill R., Brazell C. The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischemia model. Eur. J. Pharmacol. 216:1992;1-7.
8. Hondermarck H., Courty J., Boilly B., Thomas D. Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse. Experientia. 46:1990;973-974.
9. Huang, Z., Chen, K., Huang, P.L., Finklestein, S.P., Moskowitz, M.A., Basic fibroblast growth factor ameliorates focal ischemic injury in type III NOS deficient mice by rCBF-independent mechanisms. Am. J. Physiol. (in press).
10. Iadecola C., Zhang F., Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268:1995;R286-R292.
11. Jiang N., Finklestein S.P., Do T., Caday C.G., Charette M., Chopp M. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J. Neurol. Sci. 139:1996;173-179.
12. Klagsbrun M. Heparin affinity of anionic and cationic endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factor. Proc. Natl. Acad. Sci. USA. 82:1985;805-809.
13. Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67:1991;229-231.
14. Koketsu N., Berlove D.J., Moskowitz M.A., Kowall N.W., Caday C.G., Finklestein S.P. Pretreatment with intraventricular basic fibroblast growth factor (bFGF) decreases infarct size following focal cerebral ischemia in rats. Ann. Neurol. 35:1994;451-457.
15. Marchal G., Beaudouin V., Rioux P., De la Sayette V., Le Doze F., Viader F., Derlon J.M., Baron J.C. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke. 27:1996;599-606.
16. Mattson M.P., Murrain M., Guthrie P.B., Kater S.B. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9:1989;3728-3740.
17. Mattson M.P., Rychlik B., Chu C., Christakos S. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron. 6:1991;41-51.
18. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751.
19. Regli L., Anderson R.E., Meyer F.B. Basic fibroblast growth factor increases cortical blood flow in vivo. Brain Res. 665:1994;155-157.
20. Rosenblatt S., Irikura K., Caday C.G., Finklestein S.P., Moskowitz M.A. Basic fibroblast growth factor (bFGF) dilates rat pial arterioles. J. Cereb. Blood Flow Metab. 14:1994;70-74.
21. Tanaka R., Miyasaka Y., Yada K., Ohwada T., Kameya T. Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke. 26:1995;2154-2159.
22. Walicke P.A. Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8:1988;2618-2627.
23. Wanaka A., Johnson E.M., Milbrandt J. Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization. Neuron. 5:1990;267-281.
24. Whalen G.F., Shing Y., Folkman J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors. 1:1989;157-164.
25. Wiebers D.O., Adams H.P. Jr., Whisnant J.P. Animal models of stroke: are they relevant to human disease? Stroke. 21:1990;1-3.